首页 › 基金 › Slotnik Capital, LLC › RNA
Slotnik Capital, LLC 对 RNA 的持仓历史
ATRIUM THERAPEUTICS INC · 医疗保健
Slotnik Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 RNA(ATRIUM THERAPEUTICS INC)39,930 股,市值约 US$331K,约占其申报组合的 0.11%,在其申报持仓中市值排名第 27 位。 Slotnik Capital, LLC 最近 3 个申报季度中有 3 个季度披露了 RNA 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Slotnik Capital, LLC 对 RNA 的持仓演变
Slotnik Capital, LLC 于 Q1 2026 首次披露 RNA 持仓:180,945 股(约 US$2.4M)。 该持仓在 Q2 2026 达到峰值 237,637 股,市值约 US$3.2M。 在 3 次申报中,Slotnik Capital, LLC 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 39,930 股、市值约 US$331K,环比减持 -197,707 股。。 持仓曾出现大幅变动:Q2 2026 增持约 31% (随后一个季度股价下跌 38%)、Q3 2026 减持约 83% (随后一个季度股价下跌 9%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 180.94K | $2.42M | 新进 |
| Q2 2026 | 237.64K | $3.20M | 增持 |
| Q3 2026 | 39.93K | $330.62K | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RNA 与 13F 数据
RNA(ATRIUM THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 88 只申报持有 RNA,申报仓位最大的包括:Sessa Capital IM, L.P. (US$20.2M), TIG Advisors, LLC (US$7.6M), O'Connor Alternative Investments LLC (US$4.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RNA 的基金
- Sessa Capital IM, L.P. 1.50M 股 · $20.18M · Q2 2026
- TIG Advisors, LLC 561.53K 股 · $7.55M · Q2 2026
- O'Connor Alternative Investments LLC 559.14K 股 · $4.63M · Q3 2026
- Bracebridge Capital, LLC 524.48K 股 · $4.34M · Q3 2026
- Arbiter Partners Capital Management LLC 311.72K 股 · $2.58M · Q3 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 150.03K 股 · $2.02M · Q2 2026
- Kalehua Capital Management LLC 112.65K 股 · $932.76K · Q3 2026
- Athos Capital Ltd 107.97K 股 · $894.00K · Q3 2026
- Marble Bar Asset Management LLP 103.90K 股 · $860.27K · Q3 2026
- Trium Capital LLP 58.38K 股 · $483.40K · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 43.76K 股 · $362.32K · Q3 2026
- Fortress Investment Group LLC 20.00K 股 · $165.60K · Q3 2026
更多关于 Slotnik Capital, LLC
常见问题
How long has Slotnik Capital, LLC held RNA?
Slotnik Capital, LLC has disclosed RNA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Slotnik Capital, LLC's current position in RNA?
As of Q3 2026, Slotnik Capital, LLC holds 39.93K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $330.62K, representing 0.11% of its reported portfolio and ranking #27.
Has Slotnik Capital, LLC been buying or selling RNA?
In the latest 13F filing (Q3 2026), Slotnik Capital, LLC reduced its position in RNA. The position peaked in Q2 2026 at 237.64K shares.
Which other funds hold RNA?
Other major institutional holders of RNA include Sessa Capital IM, L.P., TIG Advisors, LLC, O'Connor Alternative Investments LLC, among 88 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.